HRT: a guide to the care conversation

Hormone replacement therapy, usually called HRT in the UK and hormone therapy or HT in the United States, is used to treat suitable menopause symptoms by replacing hormones whose production has changed. It can be particularly effective for troublesome hot flushes and night sweats. Whether it is appropriate depends on your symptoms, medical history, preferences and the specific treatment. [1]

HRT is not one identical prescription for everyone. Systemic and local treatments have different purposes, and the presence of a uterus affects the need for progestogen. Understanding those distinctions makes a consultation more useful than simply asking whether hormones are “safe” or “unsafe” in the abstract.

What symptoms can HRT help?

Systemic HRT is an effective option for vasomotor symptoms, meaning hot flushes and night sweats. Improvement in those symptoms may also help sleep and everyday functioning. It can prevent bone loss while being taken, although decisions about osteoporosis prevention or treatment require an individual assessment. [2]

Vaginal dryness and related local symptoms may need vaginal oestrogen, including in some people already using systemic treatment. HRT does not automatically explain or resolve every problem reported during midlife. Persistent fatigue, depression, cognitive concerns or pain may need separate assessment.

Agree on the purpose before prescribing. “Reduce night sweats so I can sleep more reliably” is a clearer target than “optimise all my hormones”. A specific goal helps the clinician judge benefit, identify adverse effects and decide whether a treatment change is warranted.

Systemic treatment and local vaginal treatment

Systemic oestrogen reaches the wider body. It may be supplied as tablets or through the skin using a patch, gel or spray, depending on the product and country. Route affects practical use and some aspects of risk. [3]

Low-dose local vaginal oestrogen is intended mainly for vaginal and urinary tissues. It is not a treatment for hot flushes or a substitute for systemic therapy when that is the symptom target. Its absorption and risk discussion differ from those of systemic treatment. [4]

The word “hormone” therefore does not tell you enough to compare two prescriptions. Ask for the exact medicine, dose form, intended benefit and relevant precautions. Our vaginal-oestrogen article covers local treatment separately so its purpose is not confused with whole-body symptom management.

Why progestogen may be necessary

For someone with a uterus, systemic oestrogen generally needs an appropriate progestogen to protect the womb lining. Oestrogen without sufficient protection can increase the risk of endometrial problems. Progestogen may be supplied in different ways, and the correct arrangement depends on the regimen. [3]

After a complete hysterectomy, oestrogen-only HRT is often possible, although particular diagnoses can change the recommendation. Your clinician needs the actual surgical history rather than an assumption based on the name of an operation.

Do not omit progestogen independently because it causes troublesome effects or seems less important. Contact the prescriber so the regimen can be reviewed safely. The purpose of one component may be protection rather than a benefit you can immediately feel, which makes clear instructions particularly important.

Sequential and continuous combined regimens

Combined HRT can be prescribed in regimens that differ in how progestogen is used and whether scheduled bleeding is expected. Sequential treatment is commonly used while periods are still occurring or around the transition; continuous combined treatment is generally used after menopause, depending on circumstances. [3]

The exact schedule belongs in the prescription instructions. Do not copy a friend’s regimen or change between patterns based only on an online description. Contraception, bleeding history, symptom response and individual risks can all affect the choice.

Ask what bleeding to expect and what should prompt contact. Unexpected bleeding is not something to dismiss indefinitely as an ordinary side effect. A clinician should interpret it in the context of the treatment and timing. The bleeding guide explains why new or persistent changes still need assessment.

Who may benefit, and when is specialist advice useful?

For many appropriately selected people with bothersome symptoms who are younger than 60 or within 10 years of menopause, the benefit-risk balance of systemic therapy can be favourable. These are clinical considerations, not an automatic eligibility test or a reason to prescribe without reviewing history. [2]

Previous hormone-sensitive cancer, unexplained bleeding, clotting problems, liver disease or significant cardiovascular history can change the decision. A specialist may be needed when the diagnosis or treatment choice is complex. Local vaginal therapy may involve a different discussion from systemic treatment.

Early menopause and premature ovarian insufficiency also need a distinct approach because replacing missing hormones can have a broader purpose. Read early menopause rather than assuming that research on starting therapy later in life applies unchanged to a younger person.

Tablets, patches, gels and practical differences

A useful choice accounts for safety and daily use. Oral and transdermal oestrogen do not have identical effects on clot risk, and personal medical history can influence the preferred route. Convenience alone should not determine the decision. [5]

Practical issues matter too: skin sensitivity, remembering applications, travel, product supply and whether the instructions fit your routine. Ask a pharmacist to demonstrate use when needed. A product cannot work as intended if application or dosing instructions are unclear.

Do not assume that similarly named products deliver equivalent amounts. If supply changes, ask the prescriber or pharmacist for an appropriate alternative and new instructions. Avoid stretching, combining or borrowing prescriptions without advice. A planned substitution is safer than guessing that two patches or gels are interchangeable.

What assessment is needed before starting?

Expect discussion of symptoms, bleeding, contraception, relevant diagnoses, surgery, family history and current medicines. A clinician may check blood pressure and arrange investigations when indicated. Routine hormone panels are not required to diagnose a typical menopause presentation in an otherwise healthy person aged 45 or over. [6]

That does not mean testing is never appropriate. Unusual bleeding, suspected early menopause or possible alternative causes of symptoms can require assessment before or alongside treatment. Ask what any proposed test would change.

Bring previous treatment experiences and concerns about adverse effects. Your preferences should be part of the decision, including a preference not to use hormones. The appointment planner can help organise these questions without attempting to decide the prescription for you.

Side effects, safety and review

Possible adverse effects vary by treatment and can include breast tenderness, headache, nausea, skin irritation or bleeding changes. Some settle, while others require review or a different regimen. Ask which effects can be discussed routinely and which need prompt medical attention. [1]

Chest pain, severe breathlessness, symptoms of a stroke or a painful swollen leg require urgent assessment. Unexpected bleeding also needs advice appropriate to the pattern. Do not simply stop and restart treatment repeatedly without discussing what is happening.

Review should assess symptom benefit, adverse effects, adherence and any change in health. NHS guidance describes review after starting treatment and then ongoing review, commonly annually once established. A prescription should come with a way to obtain help between scheduled appointments. [7]

Duration, stopping and changing the plan

There is no single duration that suits everyone. Continuing depends on benefit, risks, formulation and changing circumstances. Starting systemic therapy for the first time much later after menopause is a different decision from continuing treatment that has been reviewed over time. [2]

When stopping is considered, discuss how to do it and what to expect if symptoms return. The appropriate approach depends on the treatment and person; an internet rule about stopping at a particular birthday is not enough.

HRT is not contraception. Pregnancy prevention needs a separate plan during perimenopause and in other situations where pregnancy remains possible. Do not discontinue contraception because an HRT prescription has been issued or symptoms improve. The contraception guide explains why the roles of different hormonal medicines must be kept distinct.

Check that you can explain the purpose of every component before leaving the appointment. A combined regimen may have different instructions for different medicines, and a local vaginal product may have a separate schedule. Ask the pharmacist to clarify the supplied formulation when its name or packaging differs from what you expected. Do not assume two products are interchangeable because both contain oestrogen. Keeping the written plan with the current medicine list can reduce confusion when travelling, requesting repeats or attending another healthcare service.

What HRT should not be promised to do

HRT should not be presented as a universal anti-ageing treatment, a guaranteed weight-loss method or a prescription everyone needs to remain capable and healthy. It is not recommended solely for preventing dementia, and cardiovascular prevention is not a general reason to start it. [6] [8]

The label “bioidentical” does not automatically make a product safer. Regulated medicines can contain hormones chemically identical to those the body produces; individually compounded mixtures are a separate issue. Ask about the actual product and evidence rather than relying on marketing language. [2]

A good decision is specific and revisable: the problem being treated, the expected benefit, the relevant risks, practical instructions and a review route. Use the benefits-and-risks guide to prepare that discussion. The aim is appropriate symptom care, not pressure to accept or reject hormones as a matter of identity.